Independent valuation advisor consents to consent
The advisor of Altus Group U.S. Inc. has consented to being referenced in an upcoming Form 8-K. This approval is for inclusion in subsequent registration statements.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The advisor of Altus Group U.S. Inc. has consented to being referenced in an upcoming Form 8-K. This approval is for inclusion in subsequent registration statements.
GEE Group Inc. has postponed its virtual 2026 annual shareholder meeting originally scheduled for Sept. 24 to Sept. 30 to allow additional time for proxy solicitation. The record d…
Lion Copper Corp. announced the filing of an NI 43-101 technical report supporting its maiden MRE for the Bear Deposit, highlighting its potential within the Yerington Copper Distr…
Nasdaq granted Exicure a deadline extension through December 2, 2026 to regain compliance with its $2.5 million stockholders' equity requirement to avoid delisting.
On September 15, Bryn Inc. filed an 8-K to amend its articles of incorporation and dispatch under the Securities Exchange Act's public companies manual, signaling a strategic reduc…
Allarity Therapeutics announced the grant of a Japanese Patent (7917283) for its stenoparib Drug Response Predictor (DRP) companion diagnostic, extending patent protection through …
NRx Pharmaceuticals announced the FDA Office of Generic Drugs has reclassified a major amendment to its ketamine ANDA as a minor amendment. This designation revision lowers the reg…
West Coast Community Bancorp announced its common stock is approved for listing on Nasdaq, uplisting from OTC markets, effective September 16, 2026.
zSpace plans to deregister its stock and suspend reporting obligations by early 2027 to reduce costs. Trading will continue on OTC under ZSPC after Nasdaq delisting becomes effecti…
Beta Bionics receives FDA clearance for its new Mint patch pump and submitted the 3D Intelligence algorithm, shifting its commercialization timeline to 2026 and 2027 respectively w…
AutoNation amended its $1.1 billion senior secured credit agreement, extending the maturity date to September 2026 and adjusting revolving credit commitments. This strategic update…
Apple Hospitality REIT, Inc. filed a 2026 investor presentation that outlines strategies and forward-looking statements regarding its hotel portfolio operations. The filing serves …
Blue Owl Technology Income Corp. amended its senior secured credit agreement on September 10, 2026, by signing a Fourth Amendment.
Spectral AI has secured FDA de novo classification, now authorized to launch sales in the U.S., bolstered by $86.6M in Project BioShield funding and plans for global expansion.
Federal Home Loan Bank of New York filed an exhibit detailing the call schedule for securities including US$128m of 4.5% fixed-rate notes due 2028.
Arcadia Biosciences, Inc. filed a form 8-K to issue Exhibit 10.1, establishing a new 2026 Omnibus Equity Incentive Plan for employee compensation.
The U.S. FDA announced the final design of the new Expedited Investigational New Drug Pilot and began accepting applications.
OmniQ received a U.S. patent for AI-based vehicle occupancy detection methods used in HOV lane enforcement. The technology automates the counting of vehicle occupants at highway sp…
Summit Therapeutics announced updated overall survival results at WCLC 2026 for ivonescimab plus chemotherapy in EGFR-mutated NSCLC, maintaining efficacy and safety profiles across…
The company announced plans to expand into Georgia and Tennessee following the recent enactment of state laws establishing frameworks for certain stem cell therapies. The expansion…